ConsumerLab.com uses JavaScript to provide the best possible experience for our content, but your browser has it disabled. Learn how to enable it here.

About ConsumerLab.com

Posted June 12, 2013

Weight Loss Supplement Recalled Due To Undeclared Drugs

On June 11, 2013, Bethel Nutritional Consulting, Inc. issued a voluntary recall of one lot of Bethel 30 herbal weight loss supplement because it was found to contain undeclared sibutramine and phenolphthalein.

Sibutramine, the active ingredient in the obesity drug Meridia, was removed from the U.S. market in October 2010 because it can substantially increase blood pressure and pulse rate in some individuals, and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke. This drug may also interact, in life-threatening ways, with other medications a consumer may be taking.

Bethel 30 is packaged in white plastic bottles containing 30 green capsules per bottle and is marked with lot# 120514 and an expiration date of 12/05/2014.

It was sold online at www.bethel30.com and through direct sales from the company’s New York, NY office.

Consumers who have purchased this supplement should discontinue use immediately and contact their healthcare provider if they have experienced any adverse side effects. Consumers and healthcare providers are also encouraged to report any adverse reactions to the FDA’s MedWatch Adverse Event Reporting Program.

See ConsumerLab.com’s Review of Weight Loss Supplements for tests of related products.

See Related Warnings:

FDA Warns Consumers Of Weight Loss Supplement Containing Undeclared Drug

Weight Loss Supplement Recalled Due To Undeclared Drug

FDA Seizes Weight Loss Supplements Containing Undeclared Drug

Rx Drugs Found in Weight Loss and Enhancement Supplements

Recall of "Slimming" Supplements Spiked with Drug

To learn more about this recall, use the link below.